Trademark: 97607854
Word
FLEXASO
Status Date
Tuesday, September 17, 2024
Filing Date
Monday, September 26, 2022
Published for Opposition
Tuesday, September 17, 2024
42 Pharmaceutical research and development; research and development of pharmaceuticals and therapeutics to treat genetic and neurodegenerative diseases; research and development of pharmaceuticals and therapeutics which target the DNA of specific disease-related proteins and regulate the protein's amount and countering the diseased pathway; research and development of pharmaceuticals and therapeutics which target the RNA of specific disease-related proteins and regulate the protein's amount and countering the diseased pathway
Sep 29, 2022
New Application Entered
Oct 13, 2022
New Application Office Supplied Data Entered
Jul 8, 2024
Correspondence Received In Law Office
Jul 10, 2023
Assigned To Examiner
Jul 13, 2023
Non-Final Action Written
Jul 13, 2023
Non-Final Action E-Mailed
Jul 13, 2023
Notification Of Non-Final Action E-Mailed
Oct 10, 2023
Application Extension To Response Period - Received
Oct 10, 2023
Application Extension Granted/Receipt Provided
Jan 12, 2024
Teas Response To Office Action Received
Jul 8, 2024
Teas/Email Correspondence Entered
Jul 8, 2024
Assigned To Lie
Jul 11, 2024
Non-Final Action Written
Jul 11, 2024
Notification Of Non-Final Action E-Mailed
Aug 6, 2024
Teas Response To Office Action Received
Aug 8, 2024
Teas/Email Correspondence Entered
Aug 8, 2024
Correspondence Received In Law Office
Aug 13, 2024
Approved For Pub - Principal Register
Aug 28, 2024
Notification Of Notice Of Publication E-Mailed
Sep 17, 2024
Published For Opposition
Sep 17, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2024
Non-Final Action E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
